Jay Bhattacharya's Controversial NIH Appointment Sparks Debate
TL;DR Summary
The National Institutes of Health (NIH), once considered a prestigious and untouchable part of the U.S. government, is now facing increased scrutiny and criticism. This shift in perception is due to various factors, including political pressures and debates over its funding and research priorities. The NIH's role in public health and scientific research is being reevaluated, impacting its reputation and future operations.
- Long a ‘Crown Jewel’ of Government, N.I.H. Is Now a Target The New York Times
- What Jay Bhattacharya, Trump's NIH Pick, Has Said About Anthony Fauci Newsweek
- Trump’s Unusual Pick for NIH Director May Be a Win for These Stocks Barron's
- Trump picks Jay Bhattacharya, who backed COVID herd immunity, to lead National Institutes of Health The Associated Press
- Who Is Jay Bhattacharya? The Lockdown Critic And ‘Herd Immunity’ Backer Picked To Lead NIH. Forbes
Reading Insights
Total Reads
0
Unique Readers
13
Time Saved
0 min
vs 1 min read
Condensed
-114%
29 → 62 words
Want the full story? Read the original article
Read on The New York Times